PC
ANAB icon

PA Capital’s AnaptysBio ANAB Stock Holding History

PA Capital’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,520
Closed -$236K – 166
2019
Q4 		$236K Buy
+14,520
New +$343K 0.21% 108

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PA Capital's ANAB Position: Q1 2020 in Review

PA Capital sold out of AnaptysBio (ANAB) in Q1 2020, closing a stake of 14,520 shares — an estimated $236K sold.

PA Capital first reported a position in ANAB in Q4 2019 and held it in 1 quarter. The position peaked at $236K in Q4 2019. 116 funds tracked by Wall St. Rank hold ANAB as of Q1 2020.

  • PA Capital reported no remaining AnaptysBio position as of Q1 2020 after selling out during the quarter.
  • PA Capital sold 14,520 AnaptysBio shares in Q1 2020, an estimated $236K.
  • PA Capital first reported a position in AnaptysBio in Q4 2019 and held it in 1 quarter.
  • PA Capital's AnaptysBio position peaked at $236K in Q4 2019.
  • 116 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2020.

Based on PA Capital's 13F filing for Q1 2020, filed 11 May 2020.